Press release
The Market share for SAGE-718 by Sage Therapeutics Set to Experience Tremendous Growth by 2032.
Are you interested in finding out the projected market size of SAGE-718 in 2032? SAGE-718 Market Forecast
https://www.delveinsight.com/report-store/sage-718-emerging-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
The SAGE-718 Market Report offers projected sales forecasts for SAGE-718 for indications until 2032, categorized across the 7MM i.e. United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The report also provides extensive coverage and a competitive landscape analysis of competitors and marketed products indication. It also covers analyst views along with market drivers and barriers.
Sage Therapeutics SAGE-718 is serving as a beacon of hope for the patients suffering from Huntington's Disease.
What is SAGE-718 Prescribed for?
Sage Therapeutics, Inc. (Nasdaq: SAGE), a pioneering biopharmaceutical firm dedicated to advancing brain health, has revealed that the U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to SAGE-718 for treating Huntington's disease (HD). SAGE-718 is being developed as a potential oral treatment targeting cognitive disorders linked with dysfunction of the NMDA receptor.
The report extensively covers the details and developments related to SAGE-718, capturing important highlights on developmental pipeline, regulatory status and special designations of SAGE-718, route of administration, safety and efficacy details.
SAGE-718 Market Assessment
This report provides a detailed market assessment of SAGE-718 for Huntington's Disease in the seven major markets, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. This segment of the report provides forecasted sales data from 2028 to 2032.
SAGE-718 Clinical Assessment
The report provides the clinical trials information of SAGE-718 for Huntington's Disease covering trial interventions, trial conditions, trial status, start and completion dates. Report also includes important insights on regulatory milestones and other developmental activities related.
Do you know your drug's competitive positioning against SAGE-718? SAGE-718 Drugs Insights
https://www.delveinsight.com/sample-request/sage-718-emerging-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
SAGE-718 Competitive Landscape
The report offers insights into the key players and companies actively engaged in the development of the specified indication. It provides valuable information regarding the competitive positioning of the SAGE-718.
SAGE-718 Market Size in the US
A dedicated section of the report focuses on the expected market size of SAGE-718 for the United States. DelveInsight's analysis includes market trends, growth projections, and key factors influencing the market dynamics, offering a comprehensive perspective for stakeholders.
Key Highlights of SAGE-718:
• The report contains forecasted sales of SAGE-718 for indication till 2032.
• Comprehensive coverage of the late-stage emerging therapies for Huntington's Disease.
• The report also features the qualitative and quantitative analysis with analysts as well as KOL views for SAGE-718 in Huntington's Disease.
Stay ahead in competition by leveraging insights on SAGE-718 market Report: Download SAGE-718 Market Report
https://www.delveinsight.com/sample-request/sage-718-emerging-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Why you should buy SAGE-718 Market Report:
• The report provides future market assessments for SAGE-718 for Huntington's Disease in the 7 Major Markets, Advance qualitative analysis like SWOT, expert analysts' views, detailed overview of market competitors, and short analysis of other emerging therapies in Ulcerative Colitis.
• Leading SAGE-718 for Huntington's Disease forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the SAGE-718
• Discover the competitive landscape of SAGE-718 through 7MM
• Get a Thorough Analysis of the SAGE-718 Development pipeline, Safety & Efficacy of the SAGE-718, and ROA
• Thorough SAGE-718 market forecast will help understand how drug is competing with other emerging SAGE-718
• Get analysis of the SAGE-718 clinical trial advancements and the detailed clinical assessment, regulatory and commercial assessment
• Drug Market forecasts are calculated after taking into consideration KOL viewpoints
Related Reports By DelveInsight:
Huntington's Disease Pipeline https://www.delveinsight.com/report-store/huntingtons-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's, "Huntington's Disease Pipeline Insight, 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Huntington's Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. The key Huntington's Disease companies in the market include - Prilenia Therapeutics, Ionis Pharmaceuticals, Annexon, Vaccinex, Neurocrine Biosciences, EIP Pharma, SAGE Therapeutics, Celon Pharma, PTC Therapeutics, WaVelife Sciences, Amsterdam Molecular Therapeutics, Novartis, Retrotope, Hope Biosciences, Stealth BioTherapeutics, Luye Pharma Group, Neurimmune Therapeutics, SOLA Biosciences, and others.
It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Top Services Offered By DelveInsight:
Elevate healthcare strategies with Delveinsight Healthcare Consulting. Unlock insights, navigate challenges, and drive success in the dynamic healthcare landscape. https://www.delveinsight.com/consulting
Latest Reports Offered By DelveInsight:
Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.
Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.
Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.
Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Market share for SAGE-718 by Sage Therapeutics Set to Experience Tremendous Growth by 2032. here
News-ID: 3451132 • Views: …
More Releases from DelveInsight Business Research
DelveInsight Unveils Comprehensive Epidemiology Assessment of Cutaneous Squamous …
DelveInsight, a global leader in healthcare research and analytics, announces the release of its in-depth Cutaneous Squamous Cell Carcinoma (cSCC) Epidemiology Assessment, providing unparalleled insights into the prevalence of cSCC among solid organ transplant recipients across 15 countries, including the United States, key European nations, and select countries in the Asia-Pacific (APAC) region.
The newly released assessment delivers country-specific epidemiological insights aimed at guiding strategic decision-making for pharmaceutical companies, healthcare providers,…
Unlocking Market Potential: DelveInsight's Comprehensive Patent Foramen Ovale (P …
DelveInsight's Market Size & Forecast Assessment Provides Data-Driven Insights for Patient-Centric Market Expansion Strategies
DelveInsight, a leading healthcare market research and consulting firm, has released an in-depth case study highlighting its latest assessment of the Patent Foramen Ovale (PFO) Device Market across the European Union. This strategic market intelligence report provides a holistic understanding of the patient population, device market size, competitor landscape, and reimbursement scenario, equipping medical device companies with…
Global Chronic Obstructive Pulmonary Disease Treatment Devices Market Poised for …
The Chronic Obstructive Pulmonary Disease (COPD) Treatment Devices Market is set for strong expansion, projected to grow at a CAGR of 6.35% from 2025 to 2032, according to recent industry findings. This growth is primarily fueled by the increasing global prevalence of COPD, escalating exposure to tobacco smoke and air pollution, expanding screening programs, and the rapid development of next-generation respiratory devices such as portable nebulizers and smart inhalers.
The global…
CD40 Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CD40 pipeline constitutes key companies continuously working towards developing CD40 treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"CD40 Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the CD40 Market.
The CD40 Pipeline report embraces in-depth commercial and…
More Releases for SAGE
A Sage and Wise Choice Between Sage 50 (Simply Accounting) And Quickbooks
Brandon, MB––November 27, 2021: Sage 50 previously known as Peachtree or Simply Accounting traces its roots back to 1976 as part of The Computer SystemCenter – a microcomputer dealer. Peachtree was included in the initial launch of the first IBM PCs in 1981. By 1984, Peachtree was the seventh largest microcomputer software company generating nearly $22 million in revenue.
Sage Group acquired Peachtree in the late 1990s and changed the product…
Investigation announced for Investors in shares of Sage Therapeutics, Inc. (NASD …
An investigation on behalf of investors of Sage Therapeutics, Inc. (NASDAQ: SAGE) shares over potential securities laws violations by Sage Therapeutics, Inc. and certain of its directors and officers in connection with certain financial statements was announced.
Investors who purchased shares of Sage Therapeutics, Inc. (NASDAQ: SAGE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on…
The future of Sage SalesLogix unveiled at DMC Software with Sage workshops
Sage Saleslogix Business Partner of the Year, DMC Software Solutions, are hosting Sage SalesLogix Workshops which identify how SalesLogix CRM can support organisational growth and provide previews of the forthcoming SalesLogix developments.
The DMC Software SalesLogix Sage Events are scheduled for 28th and 29th June 2011 in Peterborough and London, respectively. CRM experts from Sage and DMC Software explore the business potential Saleslogix can help to achieve, with a look to…
Sage VARs See Continued Marketing Successes with Sage Product Newsletters
Sage ERP, CRM, HR, and Nonprofit product newsletters continue to be one of the best ways to stay in front of customers and keep them engaged with targeted content.
Laguna Hills, CA, March 09, 2011 -- Juice Marketing has revealed that their Sage ERP, CRM, HR, and nonprofit product newsletters continue to be a popular marketing tool among Sage VARs despite the growing popularity of social media like Twitter, Facebook, and…
Ecolab Puts its books in order with Sage Accpac ERP by Sage India
New Delhi, India: Ecolab, the world’s leading provider of premium cleaning, food safety and health protection products and services for the hospitality, foodservice, healthcare and industrial markets, has implemented Sage Accpac ERP and has gained better control over its finance and inventory management process Since its inception in India, the company has been witnessing growth and expansion in its business.
“As our customer base and operations expanded in the country,…
Agarwal Fasteners Tightens Operations with Sage Accpac ERP by Sage India
Agarwal Fasteners Tightens Operations with Sage Accpac ERP by Sage India
• Real time view of inventory for informed procurement
• Seamless integration of modules for zero duplication and errors
• Automatic reports generated at the touch of a button
• High data security for greater control
New Delhi : Sage India, today announced that Agarwal Fasteners Pvt. Ltd., the specialized manufacturer of critical stainless steel fasteners as per industry standards…
